{"transactions":[{"id":4137889,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-12-08T21:23:42.000Z","date":"2017-12-07","kind":"sale","acquired":false,"shares":631,"price":60.45,"value":38143.95,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $60.00 to $60.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":79515,"source":{"system":"sec-edgar","filing":"0001209191-17-064704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117064704/doc4.xml","form_type":"4"}},{"id":4137888,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-12-08T21:23:42.000Z","date":"2017-12-07","kind":"sale","acquired":false,"shares":631,"price":60.45,"value":38143.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $60.00 to $60.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":79475,"source":{"system":"sec-edgar","filing":"0001209191-17-064704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117064704/doc4.xml","form_type":"4"}},{"id":4137887,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-12-08T21:23:42.000Z","date":"2017-12-07","kind":"sale","acquired":false,"shares":288,"price":59.68,"value":17187.84,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $58.99 to $59.95. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":80146,"source":{"system":"sec-edgar","filing":"0001209191-17-064704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117064704/doc4.xml","form_type":"4"}},{"id":4137886,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-12-08T21:23:42.000Z","date":"2017-12-07","kind":"sale","acquired":false,"shares":288,"price":59.68,"value":17187.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $58.99 to $59.95. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":80106,"source":{"system":"sec-edgar","filing":"0001209191-17-064704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117064704/doc4.xml","form_type":"4"}},{"id":4137885,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-12-08T21:23:42.000Z","date":"2017-12-06","kind":"sale","acquired":false,"shares":204,"price":60.01,"value":12242.04,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $59.62 to $60.55. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":80434,"source":{"system":"sec-edgar","filing":"0001209191-17-064704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117064704/doc4.xml","form_type":"4"}},{"id":4137884,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-12-08T21:23:42.000Z","date":"2017-12-06","kind":"sale","acquired":false,"shares":204,"price":60.01,"value":12242.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $59.62 to $60.55. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":80394,"source":{"system":"sec-edgar","filing":"0001209191-17-064704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117064704/doc4.xml","form_type":"4"}},{"id":4137883,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-12-08T21:23:42.000Z","date":"2017-12-06","kind":"sale","acquired":false,"shares":254,"price":58.95,"value":14973.3,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $58.58 to $59.21. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":80638,"source":{"system":"sec-edgar","filing":"0001209191-17-064704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117064704/doc4.xml","form_type":"4"}},{"id":4137882,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-12-08T21:23:42.000Z","date":"2017-12-06","kind":"sale","acquired":false,"shares":253,"price":58.95,"value":14914.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $58.58 to $59.21. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":80598,"source":{"system":"sec-edgar","filing":"0001209191-17-064704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117064704/doc4.xml","form_type":"4"}},{"id":4137881,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-12-08T21:23:42.000Z","date":"2017-12-06","kind":"sale","acquired":false,"shares":542,"price":57.9,"value":31381.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $57.48 to $58.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":80892,"source":{"system":"sec-edgar","filing":"0001209191-17-064704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117064704/doc4.xml","form_type":"4"}},{"id":4137880,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-12-08T21:23:42.000Z","date":"2017-12-06","kind":"sale","acquired":false,"shares":543,"price":57.9,"value":31439.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $57.48 to $58.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":80851,"source":{"system":"sec-edgar","filing":"0001209191-17-064704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117064704/doc4.xml","form_type":"4"}},{"id":4162131,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-11-15T22:43:10.000Z","date":"2017-11-14","kind":"sale","acquired":false,"shares":309,"price":60.46,"value":18682.14,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $60.19 to $60.78. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":81434,"source":{"system":"sec-edgar","filing":"0001209191-17-060967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117060967/doc4.xml","form_type":"4"}},{"id":4162130,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-11-15T22:43:10.000Z","date":"2017-11-14","kind":"sale","acquired":false,"shares":309,"price":60.46,"value":18682.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $60.19 to $60.78. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":81394,"source":{"system":"sec-edgar","filing":"0001209191-17-060967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117060967/doc4.xml","form_type":"4"}},{"id":4162129,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-11-15T22:43:10.000Z","date":"2017-11-14","kind":"sale","acquired":false,"shares":691,"price":59.36,"value":41017.76,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $59.05 to $59.71. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":81743,"source":{"system":"sec-edgar","filing":"0001209191-17-060967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117060967/doc4.xml","form_type":"4"}},{"id":4162128,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-11-15T22:43:10.000Z","date":"2017-11-14","kind":"sale","acquired":false,"shares":691,"price":59.36,"value":41017.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $59.05 to $59.71. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":81703,"source":{"system":"sec-edgar","filing":"0001209191-17-060967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117060967/doc4.xml","form_type":"4"}},{"id":4162127,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-11-15T22:43:10.000Z","date":"2017-11-13","kind":"sale","acquired":false,"shares":1000,"price":62.07,"value":62070.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $61.87 to $62.45. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":82434,"source":{"system":"sec-edgar","filing":"0001209191-17-060967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117060967/doc4.xml","form_type":"4"}},{"id":4162126,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-11-15T22:43:10.000Z","date":"2017-11-13","kind":"sale","acquired":false,"shares":1000,"price":62.07,"value":62070.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $61.87 to $62.45. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":82394,"source":{"system":"sec-edgar","filing":"0001209191-17-060967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117060967/doc4.xml","form_type":"4"}},{"id":4183846,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-10-18T21:34:28.000Z","date":"2017-10-17","kind":"sale","acquired":false,"shares":1000,"price":71.1,"value":71100.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $70.71 to $71.51. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":83434,"source":{"system":"sec-edgar","filing":"0001209191-17-057318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117057318/doc4.xml","form_type":"4"}},{"id":4183845,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-10-18T21:34:28.000Z","date":"2017-10-17","kind":"sale","acquired":false,"shares":1000,"price":71.1,"value":71100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $70.71 to $71.51. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":83394,"source":{"system":"sec-edgar","filing":"0001209191-17-057318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117057318/doc4.xml","form_type":"4"}},{"id":4183844,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-10-18T21:34:28.000Z","date":"2017-10-16","kind":"sale","acquired":false,"shares":1000,"price":71.09,"value":71090.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $70.58 to $71.83. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":84434,"source":{"system":"sec-edgar","filing":"0001209191-17-057318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117057318/doc4.xml","form_type":"4"}},{"id":4183843,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-10-18T21:34:28.000Z","date":"2017-10-16","kind":"sale","acquired":false,"shares":1000,"price":71.09,"value":71090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $70.58 to $71.83. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":84394,"source":{"system":"sec-edgar","filing":"0001209191-17-057318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117057318/doc4.xml","form_type":"4"}},{"id":4208296,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-09-15T20:54:26.000Z","date":"2017-09-14","kind":"sale","acquired":false,"shares":1000,"price":65.71,"value":65710.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $65.45 to $66.34. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":85434,"source":{"system":"sec-edgar","filing":"0001209191-17-053010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117053010/doc4.xml","form_type":"4"}},{"id":4208295,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-09-15T20:54:26.000Z","date":"2017-09-14","kind":"sale","acquired":false,"shares":1000,"price":65.71,"value":65710.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $65.45 to $66.34. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":85394,"source":{"system":"sec-edgar","filing":"0001209191-17-053010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117053010/doc4.xml","form_type":"4"}},{"id":4208294,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-09-15T20:54:26.000Z","date":"2017-09-13","kind":"sale","acquired":false,"shares":1000,"price":65.47,"value":65470.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $65.15 to $65.92. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":86434,"source":{"system":"sec-edgar","filing":"0001209191-17-053010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117053010/doc4.xml","form_type":"4"}},{"id":4208293,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-09-15T20:54:26.000Z","date":"2017-09-13","kind":"sale","acquired":false,"shares":1000,"price":65.47,"value":65470.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $65.15 to $65.92. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":86394,"source":{"system":"sec-edgar","filing":"0001209191-17-053010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117053010/doc4.xml","form_type":"4"}},{"id":4225480,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-08-24T20:13:03.000Z","date":"2017-08-23","kind":"sale","acquired":false,"shares":500,"price":57.07,"value":28535.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $56.77 to $57.33. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":87434,"source":{"system":"sec-edgar","filing":"0001209191-17-050096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117050096/doc4.xml","form_type":"4"}},{"id":4225479,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-08-24T20:13:03.000Z","date":"2017-08-23","kind":"sale","acquired":false,"shares":500,"price":57.07,"value":28535.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $56.77 to $57.33. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":87394,"source":{"system":"sec-edgar","filing":"0001209191-17-050096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117050096/doc4.xml","form_type":"4"}},{"id":4225478,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-08-24T20:13:03.000Z","date":"2017-08-23","kind":"sale","acquired":false,"shares":500,"price":57.09,"value":28545.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $56.77 to $57.34. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":87934,"source":{"system":"sec-edgar","filing":"0001209191-17-050096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117050096/doc4.xml","form_type":"4"}},{"id":4225477,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-08-24T20:13:03.000Z","date":"2017-08-23","kind":"sale","acquired":false,"shares":500,"price":57.09,"value":28545.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $56.77 to $57.34. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":87894,"source":{"system":"sec-edgar","filing":"0001209191-17-050096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117050096/doc4.xml","form_type":"4"}},{"id":4225476,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-08-24T20:13:03.000Z","date":"2017-08-22","kind":"sale","acquired":false,"shares":500,"price":56.61,"value":28305.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.33 to $57.52. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":88434,"source":{"system":"sec-edgar","filing":"0001209191-17-050096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117050096/doc4.xml","form_type":"4"}},{"id":4225475,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-08-24T20:13:03.000Z","date":"2017-08-22","kind":"sale","acquired":false,"shares":500,"price":56.61,"value":28305.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.33 to $57.52. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":88394,"source":{"system":"sec-edgar","filing":"0001209191-17-050096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117050096/doc4.xml","form_type":"4"}},{"id":4225474,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-08-24T20:13:03.000Z","date":"2017-08-22","kind":"sale","acquired":false,"shares":500,"price":56.63,"value":28315.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $55.31 to $57.52. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This amount reflects 4,197 shares transferred from a grantor retained annuity trust distribution on July 28, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":88934,"source":{"system":"sec-edgar","filing":"0001209191-17-050096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117050096/doc4.xml","form_type":"4"}},{"id":4225473,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-08-24T20:13:03.000Z","date":"2017-08-22","kind":"sale","acquired":false,"shares":500,"price":56.63,"value":28315.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $55.31 to $57.52. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount reflects 4,197 shares transferred from indirect to direct ownership from a grantor retained annuity trust distribution on July 28, 2017."}],"balance_after":88894,"source":{"system":"sec-edgar","filing":"0001209191-17-050096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117050096/doc4.xml","form_type":"4"}},{"id":4253226,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-07-21T20:05:47.000Z","date":"2017-07-20","kind":"sale","acquired":false,"shares":500,"price":57.13,"value":28565.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $56.18 to $57.59. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":85237,"source":{"system":"sec-edgar","filing":"0001209191-17-045921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117045921/doc4.xml","form_type":"4"}},{"id":4253225,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-07-21T20:05:47.000Z","date":"2017-07-20","kind":"sale","acquired":false,"shares":500,"price":57.13,"value":28565.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $56.18 to $57.59. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":85197,"source":{"system":"sec-edgar","filing":"0001209191-17-045921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117045921/doc4.xml","form_type":"4"}},{"id":4253224,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-07-21T20:05:47.000Z","date":"2017-07-20","kind":"sale","acquired":false,"shares":500,"price":57.12,"value":28560.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $56.18 to $57.58. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":85737,"source":{"system":"sec-edgar","filing":"0001209191-17-045921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117045921/doc4.xml","form_type":"4"}},{"id":4253223,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-07-21T20:05:47.000Z","date":"2017-07-20","kind":"sale","acquired":false,"shares":500,"price":57.12,"value":28560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $56.18 to $57.58. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":85697,"source":{"system":"sec-edgar","filing":"0001209191-17-045921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117045921/doc4.xml","form_type":"4"}},{"id":4253222,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-07-21T20:05:47.000Z","date":"2017-07-19","kind":"sale","acquired":false,"shares":500,"price":56.11,"value":28055.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $55.85 to $56.49. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":86237,"source":{"system":"sec-edgar","filing":"0001209191-17-045921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117045921/doc4.xml","form_type":"4"}},{"id":4253221,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-07-21T20:05:47.000Z","date":"2017-07-19","kind":"sale","acquired":false,"shares":500,"price":56.11,"value":28055.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $55.85 to $56.49. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":86197,"source":{"system":"sec-edgar","filing":"0001209191-17-045921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117045921/doc4.xml","form_type":"4"}},{"id":4253220,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-07-21T20:05:47.000Z","date":"2017-07-19","kind":"sale","acquired":false,"shares":3000,"price":56.15,"value":168450.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $55.79 to $56.72. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":86737,"source":{"system":"sec-edgar","filing":"0001209191-17-045921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117045921/doc4.xml","form_type":"4"}},{"id":4253219,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-07-21T20:05:47.000Z","date":"2017-07-19","kind":"sale","acquired":false,"shares":3000,"price":56.15,"value":168450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $55.79 to $56.72. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":86697,"source":{"system":"sec-edgar","filing":"0001209191-17-045921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117045921/doc4.xml","form_type":"4"}},{"id":4280647,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-06-15T21:02:51.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted on June 13, 2017. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2018."}],"balance_after":8500,"derivative":{"exercise_price":50.73,"expiration_date":"2027-06-12","underlying":"Common stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001209191-17-040187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117040187/doc4.xml","form_type":"4"}},{"id":4280646,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-06-15T21:02:51.000Z","date":"2017-06-14","kind":"sale","acquired":false,"shares":500,"price":51.09,"value":25545.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $50.28 to $51.43. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":89737,"source":{"system":"sec-edgar","filing":"0001209191-17-040187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117040187/doc4.xml","form_type":"4"}},{"id":4280645,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-06-15T21:02:51.000Z","date":"2017-06-14","kind":"sale","acquired":false,"shares":500,"price":51.09,"value":25545.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $50.28 to $51.43. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":89697,"source":{"system":"sec-edgar","filing":"0001209191-17-040187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117040187/doc4.xml","form_type":"4"}},{"id":4280644,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-06-15T21:02:51.000Z","date":"2017-06-13","kind":"sale","acquired":false,"shares":500,"price":50.64,"value":25320.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $50.10 to $50.97. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":90237,"source":{"system":"sec-edgar","filing":"0001209191-17-040187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117040187/doc4.xml","form_type":"4"}},{"id":4280643,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-06-15T21:02:51.000Z","date":"2017-06-13","kind":"sale","acquired":false,"shares":500,"price":50.64,"value":25320.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $50.10 to $50.97. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":90197,"source":{"system":"sec-edgar","filing":"0001209191-17-040187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117040187/doc4.xml","form_type":"4"}},{"id":4304676,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-05-25T23:03:47.000Z","date":"2017-05-25","kind":"sale","acquired":false,"shares":509,"price":46.92,"value":23882.28,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $46.41 to $47.50. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":90737,"source":{"system":"sec-edgar","filing":"0001209191-17-035585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117035585/doc4.xml","form_type":"4"}},{"id":4304675,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-05-25T23:03:47.000Z","date":"2017-05-25","kind":"sale","acquired":false,"shares":509,"price":46.92,"value":23882.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $46.41 to $47.50. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":90697,"source":{"system":"sec-edgar","filing":"0001209191-17-035585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117035585/doc4.xml","form_type":"4"}},{"id":4304674,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-05-25T23:03:47.000Z","date":"2017-05-24","kind":"sale","acquired":false,"shares":509,"price":47.27,"value":24060.43,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $46.64 to $47.72. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":91246,"source":{"system":"sec-edgar","filing":"0001209191-17-035585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117035585/doc4.xml","form_type":"4"}},{"id":4304673,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-05-25T23:03:47.000Z","date":"2017-05-24","kind":"sale","acquired":false,"shares":509,"price":47.27,"value":24060.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $46.64 to $47.72. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":91206,"source":{"system":"sec-edgar","filing":"0001209191-17-035585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117035585/doc4.xml","form_type":"4"}},{"id":4349634,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-04-19T21:16:44.000Z","date":"2017-04-18","kind":"sale","acquired":false,"shares":509,"price":50.92,"value":25918.28,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $50.10 to $51.84. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":91755,"source":{"system":"sec-edgar","filing":"0001209191-17-027509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117027509/doc4.xml","form_type":"4"}},{"id":4349633,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-04-19T21:16:44.000Z","date":"2017-04-18","kind":"sale","acquired":false,"shares":509,"price":50.92,"value":25918.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $50.10 to $51.84. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":91715,"source":{"system":"sec-edgar","filing":"0001209191-17-027509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117027509/doc4.xml","form_type":"4"}},{"id":4349632,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-04-19T21:16:44.000Z","date":"2017-04-17","kind":"sale","acquired":false,"shares":1527,"price":55.27,"value":84397.29,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.00 to $55.49. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":92264,"source":{"system":"sec-edgar","filing":"0001209191-17-027509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117027509/doc4.xml","form_type":"4"}},{"id":4349631,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-04-19T21:16:44.000Z","date":"2017-04-17","kind":"sale","acquired":false,"shares":1527,"price":55.27,"value":84397.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.00 to $55.49. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":92224,"source":{"system":"sec-edgar","filing":"0001209191-17-027509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117027509/doc4.xml","form_type":"4"}},{"id":4349630,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-04-19T21:16:44.000Z","date":"2017-04-17","kind":"sale","acquired":false,"shares":509,"price":55.13,"value":28061.17,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $54.83 to $55.50. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":93791,"source":{"system":"sec-edgar","filing":"0001209191-17-027509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117027509/doc4.xml","form_type":"4"}},{"id":4349629,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-04-19T21:16:44.000Z","date":"2017-04-17","kind":"sale","acquired":false,"shares":509,"price":55.13,"value":28061.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $54.83 to $55.50. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":93751,"source":{"system":"sec-edgar","filing":"0001209191-17-027509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117027509/doc4.xml","form_type":"4"}},{"id":4372499,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-03-24T20:20:54.000Z","date":"2017-03-23","kind":"sale","acquired":false,"shares":509,"price":53.91,"value":27440.19,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $53.50 to $54.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":94300,"source":{"system":"sec-edgar","filing":"0001209191-17-022761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117022761/doc4.xml","form_type":"4"}},{"id":4372498,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-03-24T20:20:54.000Z","date":"2017-03-23","kind":"sale","acquired":false,"shares":509,"price":53.91,"value":27440.19,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $53.50 to $54.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":94260,"source":{"system":"sec-edgar","filing":"0001209191-17-022761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117022761/doc4.xml","form_type":"4"}},{"id":4372497,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-03-24T20:20:54.000Z","date":"2017-03-22","kind":"sale","acquired":false,"shares":509,"price":52.31,"value":26625.79,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $51.50 to $52.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":94809,"source":{"system":"sec-edgar","filing":"0001209191-17-022761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117022761/doc4.xml","form_type":"4"}},{"id":4372496,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-03-24T20:20:54.000Z","date":"2017-03-22","kind":"sale","acquired":false,"shares":509,"price":52.31,"value":26625.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $51.50 to $52.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":94769,"source":{"system":"sec-edgar","filing":"0001209191-17-022761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117022761/doc4.xml","form_type":"4"}},{"id":4572920,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2016-10-28T20:03:35.000Z","date":"2016-10-27","kind":"sale","acquired":false,"shares":625,"price":48.97,"value":30606.25,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $48.26 to $49.68. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":107818,"source":{"system":"sec-edgar","filing":"0001209191-16-147275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919116147275/doc4.xml","form_type":"4"}},{"id":4572919,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2016-10-28T20:03:35.000Z","date":"2016-10-27","kind":"sale","acquired":false,"shares":627,"price":48.97,"value":30704.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $48.26 to $49.68. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":107778,"source":{"system":"sec-edgar","filing":"0001209191-16-147275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919116147275/doc4.xml","form_type":"4"}},{"id":4572918,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2016-10-28T20:03:35.000Z","date":"2016-10-26","kind":"sale","acquired":false,"shares":625,"price":48.91,"value":30568.75,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $48.49 to $49.45. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":108443,"source":{"system":"sec-edgar","filing":"0001209191-16-147275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919116147275/doc4.xml","form_type":"4"}},{"id":4572917,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2016-10-28T20:03:35.000Z","date":"2016-10-26","kind":"sale","acquired":false,"shares":627,"price":48.91,"value":30666.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $48.49 to $49.45. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":108405,"source":{"system":"sec-edgar","filing":"0001209191-16-147275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919116147275/doc4.xml","form_type":"4"}},{"id":4593234,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2016-09-28T21:29:01.000Z","date":"2016-09-28","kind":"sale","acquired":false,"shares":625,"price":54,"value":33750.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $52.71 to $54.26. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":109068,"source":{"system":"sec-edgar","filing":"0001209191-16-143040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919116143040/doc4.xml","form_type":"4"}},{"id":4593233,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2016-09-28T21:29:01.000Z","date":"2016-09-28","kind":"sale","acquired":false,"shares":627,"price":54,"value":33858.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $52.71 to $54.26. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":109032,"source":{"system":"sec-edgar","filing":"0001209191-16-143040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919116143040/doc4.xml","form_type":"4"}},{"id":4593232,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2016-09-28T21:29:01.000Z","date":"2016-09-27","kind":"sale","acquired":false,"shares":625,"price":54.15,"value":33843.75,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $53.63 to $54.56. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vicki Lee Sato, who is the reporting person's spouse."}],"balance_after":109693,"source":{"system":"sec-edgar","filing":"0001209191-16-143040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919116143040/doc4.xml","form_type":"4"}},{"id":4593231,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":171286,"kind":"person","name":"Cantley Lewis Clayton Jr.","position":1,"cik":"0001581950","reported_name":"Cantley Lewis Clayton Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2016-09-28T21:29:01.000Z","date":"2016-09-27","kind":"sale","acquired":false,"shares":627,"price":54.15,"value":33952.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $53.63 to $54.56. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":109659,"source":{"system":"sec-edgar","filing":"0001209191-16-143040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919116143040/doc4.xml","form_type":"4"}}]}